Lazard Asset Management
ROIV icon

Lazard Asset Management’s Roivant Sciences ROIV Stock Holding History

Lazard Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,147
Closed -$91K – 2334
2023
Q4 		$91K Buy
+8,147
New +$79.4K ﹤0.01% 1696
2023
Q3 		– Sell
-34,078
Closed -$343K – 2448
2023
Q2 		$343K Buy
+34,078
New +$305K ﹤0.01% 1203

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Lazard Asset Management's ROIV Position: Q1 2024 in Review

Lazard Asset Management sold out of Roivant Sciences (ROIV) in Q1 2024, closing a stake of 8,147 shares — an estimated $91K sold.

Lazard Asset Management first reported a position in ROIV in Q2 2023 and held it in 2 quarters. The position peaked at $343K in Q2 2023. 259 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.

  • Lazard Asset Management reported no remaining Roivant Sciences position as of Q1 2024 after selling out during the quarter.
  • Lazard Asset Management sold 8,147 Roivant Sciences shares in Q1 2024, an estimated $91K.
  • Lazard Asset Management first reported a position in Roivant Sciences in Q2 2023 and held it in 2 quarters.
  • Lazard Asset Management's Roivant Sciences position peaked at $343K in Q2 2023.
  • 259 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.